Correction to: Therapeutic effect of platelet-rich plasma on glucocorticoid-induced rat bone marrow mesenchymal stem cells in vitro

Correction to: BMC Musculoskelet Disord 23, 151 (2022)

https://doi.org/10.1186/s12891-022-05094-2

Following the publication of the original article [1] the authors reported that legend order of Figs. 2 and 3 was wrongly reversed.

The original article [1] has been updated.

Below are Figs. 2 and 3 with the correct legends.

Fig. 2

PRP resisted the apoptosis induced by Dex in BMSCs. A TUNEL assay evaluated cell apoptosis. B Western blot analysis shows the expression for Bcl-2 and Caspase-3 apoptosis-related protein in BMSCs exposed to Dex and co-treated with PRP. GAPDH served as an endogenous control. (*p < 0.05 vs. Dex group)

Fig. 3

PRP alleviated the inhibitory effects of Dex on osteogenic differentiation of BMSCs. A and B After induction of osteogenic differentiation, ALP activity and calcium deposition were detected by ALP staining (7 d) and alizarin red staining (14 d), respectively, and quantitative analysis was performed. C Western blot analysis shows the expression for RUNX2 osteogenesis-related protein in BMSCs exposed to Dex and co-treated with PRP. GAPDH served as an endogenous control. (*p < 0.05 vs. Dex group)